Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

Neurocrit Care · 2022 · PMC9053840 · PMID 35488169

Europe PMC DOI

hedged sentence

0.4300

closest p · 8.6× alpha

0.4300

boldest claim

The sentences

a slight trendp = 0.43not close (p > 0.1)

In that study, change in anxiety and depression level was not significantly different between two groups, although there was a slight trend toward more improvement in the vinpocetine group ( p = 0.43, 0.29 respectively).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.